Is implantable cardioverter defibrillator surgery in patients with an implanted left ventricular assist device safe

Maximilian Vondran1,2, Konstantin von Aspern1, Jens Garbade1

  • 1University Department for Cardiac Surgery, Heart Center Leipzig, Leipzig, Germany.

Artificial Organs
|February 22, 2022
PubMed

Insights

Uninterrupted oral anticoagulation for patients with left ventricular assist devices (LVAD) undergoing implantable cardioverter-defibrillator (ICD) surgery is safe. This strategy significantly reduces hospital stay without increasing adverse events compared to heparin bridging.

Area of Science:

  • Cardiology
  • Medical Devices
  • Surgical Procedures

Background:

  • Implantable cardioverter-defibrillator (ICD) surgery in patients with left ventricular assist devices (LVAD) carries a high bleeding risk due to necessary anticoagulation.
  • Current practices often involve heparin bridging, which may increase complications.

Purpose of the Study:

  • To evaluate the safety and efficacy of uninterrupted oral anticoagulation versus heparin bridging during ICD surgery in LVAD patients.
  • To compare bleeding complications, re-exploratory surgery rates, and hospital length of stay between the two anticoagulation strategies.

Main Methods:

  • A retrospective study of 116 LVAD patients undergoing ICD surgery between January 2009 and January 2020.
  • Patients were divided into two groups: continued oral anticoagulation with a vitamin K antagonist (VKA group, n=60) and heparin bridging (heparin group, n=56).
  • Demographics, perioperative data, complications, and mortality were analyzed.

Main Results:

  • The heparin group showed a trend towards more bleeding complications (19.6% vs. 10.0%) and re-exploratory surgeries (14.3% vs. 5.0%), though not statistically significant.
  • Patients in the heparin group had a significantly longer postoperative hospital stay (17.8 days vs. 8.3 days, p=0.007).
  • No procedure-related deaths, thromboembolic events, or LVAD thrombosis were observed in either group.

Conclusions:

  • Uninterrupted oral anticoagulation is a safe strategy for LVAD patients undergoing ICD surgery.
  • This approach more than halves the number of hospital days without an increase in adverse events.
  • The findings support a shift towards uninterrupted anticoagulation in this high-risk patient population.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
56
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
240
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.4K
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
250
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
43
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
33